ArticleCancers2022

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.

Sylvain Garciaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.